Author

Issiaka Soulama

Centre National de Recherche et de Recherche sur le Paludisme - Cited by 1,808 - G

Biography

Dr. Issiaka Soulama Scientist/ Head of the Molecular Biology Lab Company NameNational Center for Malaria Research and Training/Burkina Faso. Dr. has special research interest in Malaria, Malaria Vaccines, Malaria falciparum, Malaria vivax, Parasitology, Parasitism
Title
Cited by
Year
PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study
SB Sirima, L Richert, A Chêne, AT Konate, C Campion, S Dechavanne, ...The Lancet Infectious Diseases 20 (5), 585-597, 2020202
82
2020
Higher gametocyte production and mosquito infectivity in chronic compared to incident Plasmodium falciparum infections
A Barry, J Bradley, W Stone, MW Guelbeogo, K Lanke, A Ouedraogo, ...Nature communications 12 (1), 2443, 2021202
45
2021
A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in …
Y Adoke, R Zoleko-Manego, S Ouoba, AB Tiono, G Kaguthi, JE Bonzela, ...Malaria Journal 20 (1), 1-25, 2021202
31
2021
Biology of Plasmodium falciparum gametocyte sex ratio and implications in malaria parasite transmission
NB Henry, SS Sermé, G Siciliano, S Sombié, A Diarra, AS Traoré, ...Malaria journal 18 (1), 1-8, 2019201
27
2019
Safety and immunogenicity of co-administration of meningococcal type A and measles–rubella vaccines with typhoid conjugate vaccine in children aged 15–23 months in Burkina Faso
SB Sirima, A Ouedraogo, N Barry, M Siribie, AB Tiono, I Nébié, AT Konaté, ...International Journal of Infectious Diseases 102, 517-523, 2021202
24
2021
Safety and immunogenicity of Vi-typhoid conjugate vaccine co-administration with routine 9-month vaccination in Burkina Faso: a randomized controlled phase 2 trial
SB Sirima, A Ouedraogo, N Barry, M Siribie, A Tiono, I Nébié, A Konaté, ...International Journal of Infectious Diseases 108, 465-472, 2021202
19
2021
Metabolome modulation of the host adaptive immunity in human malaria
W Abdrabou, MM Dieng, A Diawara, SS Sermé, D Almojil, S Sombié, ...Nature Metabolism 3 (7), 1001-1016, 2021202
18
2021
Extended spectrum beta-lactamase and fluoroquinolone resistance genes among Escherichia coli and Salmonella isolates from children with diarrhea, Burkina Faso
R Dembélé, A Konaté, O Traoré, WAD Kaboré, I Soulama, A Kagambèga, ...BMC pediatrics 20, 1-9, 2020202
14
2020
The pan African vivax and ovale network (PAVON): Refocusing on Plasmodium vivax, ovale and asymptomatic malaria in sub-Saharan Africa
IK Quaye, L Aleksenko, C Oeuvray, D Yewhalaw, N Duah, B Gyan, ...Parasitology International 84, 2415, 2021202
10
2021
Genotype Analysis of Clinical Candida albicans Isolates Using PCRs Targeting 25S rDNA and ALT Repeat Sequences of the RPS and Antifungal Susceptibility in …
PM Sawadogo, A Zida, I Soulama, SS Sermé, KT Guiguemdé, R Junior, ...Infection and Drug Resistance, 3859-3866, 2019201
10
2019
Integrative genomic analysis reveals mechanisms of immune evasion in P. falciparum malaria
MM Dieng, A Diawara, V Manikandan, H Tamim El Jarkass, SS Sermé, ...Nature communications 11 (1), 503, 2020202
9
2020
Persistent submicroscopic plasmodium falciparum parasitemia 72 hours after treatment with artemether-lumefantrine predicts 42-day treatment failure in Mali and Burkina Faso
KB Beshir, N Diallo, FA Somé, S Sombie, I Zongo, B Fofana, A Traore, ...Antimicrobial agents and chemotherapy 65 (), 10.112/aac. 0073-21, 2021202
8
2021
Investigating the impact of enhanced community case management and monthly screening and treatment on the transmissibility of malaria infections in Burkina Faso: study protocol …
KA Collins, A Ouedraogo, WM Guelbeogo, SS Awandu, W Stone, ...BMJ open 9 (9), e03059, 2019201
8
2019
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated …
M Siribie, AM Tchouatieu, I Soulama, JMT Kaboré, Y Nombré, D Hien, ...BMJ open 11 (2), e040220, 2021202
5
2021
Increased gametocyte production and mosquito infectivity in chronic versus incident Plasmodium falciparum infections
A Barry, J Bradley, W Stone, MW Guelbeogo, K Lanke, A Ouedraogo, ...medRxiv, 2020.04. 08.2007927, 2020202
5
2020
Attitudes, practices, and determinants of community care-seeking behaviours for fever/malaria episodes in the context of the implementation of multiple first-line therapies for …
JMT Kaboré, M Siribié, D Hien, I Soulama, N Barry, Y Nombré, F Dianda, ...Malaria Journal 21 (1), 155, 2022202
4
2022
Stakeholder perceptions on the deployment of multiple first-line therapies for uncomplicated malaria: A qualitative study in the health district of Kaya, Burkina Faso
D Hien, JMT Kaboré, M Siribié, I Soulama, N Barry, A Baguiya, AB Tiono, ...Malaria Journal 21 (1), 202, 2022202
3
2022
Involvement of class 1 and class 2 integrons in dissemination of tet and catA1 resistance genes of Salmonella enterica from children with diarrhea in rural Burkina Faso
R Dembélé, WAD Kaboré, I Soulama, A Konaté, A Kagambèga, O Traoré, ...African Journal of Biotechnology. 2020b 19 (1), 1-7, 2020202
3
2020
Molecular characterization of carbapenemase-producing Enterobacterales in children with diarrhea in rural Burkina Faso
R Dembélé, I Soulama, WAD Kaboré, A Konaté, A Kagambèga, ...Journal of Drug Delivery and Therapeutics 11 (1), 84-92, 2021202
3
2021
Risk of Plasmodium falciparum infection in south-west Burkina Faso: potential impact of expanding eligibility for seasonal malaria chemoprevention
JB Yaro, AB Tiono, A Ouedraogo, B Lambert, ZA Ouedraogo, A Diarra, ...Scientific Reports 12 (1), 1402, 2022202
3
2022

Referred From: https://scholar.google.com/citations?user=tD3j3tQAAAAJ&hl=fr

Cited by
Citations 1808
h-index 23
i10-index 38
Recommended Journals
Open Access Journals